Robert M. Williams
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert M. Williams has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Jennifer M. Finefield
Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, USA
11 shared publicationsDavid H. Sherman
Life Sciences Institute and Department of Medicinal Chemistry, The University of Michigan, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, USA
9 shared publicationsThomas J. Greshock
Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, United States, Life Sciences Institute and Department of Medicinal Chemistry, The University of Michigan, 210 Washtenaw Avenue, Ann Arbor, Michigan 48109-2216, United States, and Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto, 862-0973, Japan
9 shared publications- Sachiko Tsukamoto
Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan
8 shared publications James D. Sunderhaus
Department of Chemistry, Colorado State University, 1301 Center Avenue, Fort Collins, Colorado 80523, USA
6 shared publications- David H. Sherman
Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA
5 shared publications
Latest Publications
- 24 January 2015
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 75 (4) , 671-682
Comparative pharmacokinetic properties and antitumor activity of the marine HDACi Largazole and Largazole peptide isostere
Purpose Largazole is a potent class I-selective HDACi natural product isolated from the marine cyanobacteria Symploca sp. The purpose of this study was to test synthetic analogs of Largazole to identify potential scaffold structural modifications that would improve the drug-like properties of this clinically relevant natural product. Methods The impact of Largazole scaffold replacements on in vitro growth inhibition, cell cycle arrest, induction of apoptosis, pharmacokinetic properties, and in vivo activity using a xenograft model was investigated. Results In vitro studies in colon, lung, and pancreatic cancer cell lines showed that pyridyl-substituted Largazole analogs had low-nanomolar/high-picomolar antiproliferative activity, and induced apoptosis and cell cycle arrest at concentrations equivalent to or lower than the parent compound Largazole. Using IV bolus delivery at 5 mg/kg, two compartmental pharmacokinetic modeling on the peptide isostere analog of Largazole indicated improved pharmacokinetic parameters. In an A549 non-small cell lung carcinoma xenograft model using a dosage of 5 mg/kg administered intraperitoneally every other day, Largazole, Largazole thiol, and Largazole peptide isostere demonstrated tumor growth inhibition (TGI %) of 32, 44, and 66 %, respectively. Largazole peptide isostere treatment was statistically superior to control (p = 0.002) and to Largazole (p = 0.006). Surprisingly, tumor growth inhibition was not observed with the potent pyridyl-based analogs. Conclusions These results establish that replacing the depsipeptide linkage in Largazole with an amide may impart pharmacokinetic and therapeutic advantage and that alternative prodrug forms of Largazole are feasible.
- 24 January 2015
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 75 (4) , 671-682
Comparative pharmacokinetic properties and antitumor activity of the marine HDACi Largazole and Largazole peptide isostere
Purpose Largazole is a potent class I-selective HDACi natural product isolated from the marine cyanobacteria Symploca sp. The purpose of this study was to test synthetic analogs of Largazole to identify potential scaffold structural modifications that would improve the drug-like properties of this clinically relevant natural product. Methods The impact of Largazole scaffold replacements on in vitro growth inhibition, cell cycle arrest, induction of apoptosis, pharmacokinetic properties, and in vivo activity using a xenograft model was investigated. Results In vitro studies in colon, lung, and pancreatic cancer cell lines showed that pyridyl-substituted Largazole analogs had low-nanomolar/high-picomolar antiproliferative activity, and induced apoptosis and cell cycle arrest at concentrations equivalent to or lower than the parent compound Largazole. Using IV bolus delivery at 5 mg/kg, two compartmental pharmacokinetic modeling on the peptide isostere analog of Largazole indicated improved pharmacokinetic parameters. In an A549 non-small cell lung carcinoma xenograft model using a dosage of 5 mg/kg administered intraperitoneally every other day, Largazole, Largazole thiol, and Largazole peptide isostere demonstrated tumor growth inhibition (TGI %) of 32, 44, and 66 %, respectively. Largazole peptide isostere treatment was statistically superior to control (p = 0.002) and to Largazole (p = 0.006). Surprisingly, tumor growth inhibition was not observed with the potent pyridyl-based analogs. Conclusions These results establish that replacing the depsipeptide linkage in Largazole with an amide may impart pharmacokinetic and therapeutic advantage and that alternative prodrug forms of Largazole are feasible.
- 1 January 2015
- Published by Elsevier in Tetrahedron Letters
- Vol. 56 (1) , 247-251
Bioconversion of 6-epi-Notoamide T produces metabolites of unprecedented structures in a marine-derived Aspergillus sp.
- 1 January 2015
- Published by Elsevier in Tetrahedron Letters
- Vol. 56 (1) , 247-251
Bioconversion of 6-epi-Notoamide T produces metabolites of unprecedented structures in a marine-derived Aspergillus sp.
- 2 October 2014
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 32 (2) , 328-347
Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics
The ecteinascidin family comprises a number of biologically active compounds, containing two to three tetrahydroisoquinoline subunits.
- 2 October 2014
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 32 (2) , 328-347
Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics
The ecteinascidin family comprises a number of biologically active compounds, containing two to three tetrahydroisoquinoline subunits.
- 1 October 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (43) , 7942-7949
Synthetic studies towards zetekitoxin AB: preparation of 4,5-epi-11-hydroxy-saxitoxinol
- 1 October 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (43) , 7942-7949
Synthetic studies towards zetekitoxin AB: preparation of 4,5-epi-11-hydroxy-saxitoxinol
- 9 May 2014
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 31 (10) , 1376-1404
Epidithiodioxopiperazines. occurrence, synthesis and biogenesis
Covering: 1936 to 2013 Epidithiodioxopiperazine alkaloids possess an astonishing array of molecular architecture and generally exhibit potent biological activity. Nearly twenty distinct families have been isolated and characterized since the seminal discovery of gliotoxin in 1936. Numerous biosynthetic investigations offer a glimpse at the relative ease with which Nature is able to assemble this class of molecules, while providing synthetic chemists inspiration for the development of more efficient syntheses. Herein, we discuss the isolation and characterization, proposed fungal biogeneses, and total syntheses of epidithiodioxopiperazines.
- 9 May 2014
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 31 (10) , 1376-1404
Epidithiodioxopiperazines. occurrence, synthesis and biogenesis
Covering: 1936 to 2013 Epidithiodioxopiperazine alkaloids possess an astonishing array of molecular architecture and generally exhibit potent biological activity. Nearly twenty distinct families have been isolated and characterized since the seminal discovery of gliotoxin in 1936. Numerous biosynthetic investigations offer a glimpse at the relative ease with which Nature is able to assemble this class of molecules, while providing synthetic chemists inspiration for the development of more efficient syntheses. Herein, we discuss the isolation and characterization, proposed fungal biogeneses, and total syntheses of epidithiodioxopiperazines.
- 1 January 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (2) , 276-279
Efficient synthesis of the cyclopentanone fragrances (Z)-3-(2-oxopropyl)-2-(pent-2-en-1-yl)cyclopentanone and Magnolione®
- 1 January 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (2) , 276-279
Efficient synthesis of the cyclopentanone fragrances (Z)-3-(2-oxopropyl)-2-(pent-2-en-1-yl)cyclopentanone and Magnolione®
- 1 September 2013
- Published by Elsevier in Tetrahedron
- Vol. 69 (35) , 7505-7512
Synthetic studies on lemonomycin: construction of the tetracyclic core
- 1 September 2013
- Published by Elsevier in Tetrahedron
- Vol. 69 (35) , 7505-7512
Synthetic studies on lemonomycin: construction of the tetracyclic core
- 14 January 2013
- Published by Elsevier in Tetrahedron
- Vol. 69 (2) , 770-773
Studies on the biosynthesis of chetomin: enantiospecific synthesis of a putative, late-stage biosynthetic intermediate
- 14 January 2013
- Published by Elsevier in Tetrahedron
- Vol. 69 (2) , 770-773
Studies on the biosynthesis of chetomin: enantiospecific synthesis of a putative, late-stage biosynthetic intermediate
- 18 December 2012
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 15 (1) , 22-25
Synthesis and Bioconversions of Notoamide T: A Biosynthetic Precursor to Stephacidin A and Notoamide B
In an effort to further elucidate the biogenesis of the stephacidin and notoamide families of natural products, notoamide T has been identified as the likely precursor to stephacidin A. The total synthesis of notoamide T is described along with it is C-6-epimer, 6-epi-notoamide T. The chemical conversion of stephacidin A to notoamide T by reductive ring opening is described as well as the oxidative conversion of notoamide T to stephacidin A. Furthermore, [13C]2-notoamide T was synthesized and provided to Aspergillus versicolor and Aspergillus sp. MF297-2, in which significant incorporation was observed in the advanced metabolite, notoamide B.
- 18 December 2012
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 15 (1) , 22-25
Synthesis and Bioconversions of Notoamide T: A Biosynthetic Precursor to Stephacidin A and Notoamide B
In an effort to further elucidate the biogenesis of the stephacidin and notoamide families of natural products, notoamide T has been identified as the likely precursor to stephacidin A. The total synthesis of notoamide T is described along with it is C-6-epimer, 6-epi-notoamide T. The chemical conversion of stephacidin A to notoamide T by reductive ring opening is described as well as the oxidative conversion of notoamide T to stephacidin A. Furthermore, [13C]2-notoamide T was synthesized and provided to Aspergillus versicolor and Aspergillus sp. MF297-2, in which significant incorporation was observed in the advanced metabolite, notoamide B.
- 3 May 2012
- Published by Wiley in Angewandte Chemie
- Vol. 124 (20) , 4886-4920
Enantiomere Naturstoffe: Vorkommen und Biogenese
In der Natur werden chirale Substanzen meist in enantiomerenreiner Form synthetisiert – manchmal entstehen aber auch beide Enantiomere. Solche enantiomeren Naturstoffe können von einer Art oder von verschiedenen Gattungen und/oder Arten gebildet werden. Intensive Forschungen wurden über viele Jahre durchgeführt, um die Biogenese natürlich vorkommender Enantiomere zu verstehen, doch viele faszinierende Rätsel und stereochemische Anomalien sind nach wie vor ungelöst.
- 3 May 2012
- Published by Wiley in Angewandte Chemie
- Vol. 124 (20) , 4886-4920
Enantiomere Naturstoffe: Vorkommen und Biogenese
In der Natur werden chirale Substanzen meist in enantiomerenreiner Form synthetisiert – manchmal entstehen aber auch beide Enantiomere. Solche enantiomeren Naturstoffe können von einer Art oder von verschiedenen Gattungen und/oder Arten gebildet werden. Intensive Forschungen wurden über viele Jahre durchgeführt, um die Biogenese natürlich vorkommender Enantiomere zu verstehen, doch viele faszinierende Rätsel und stereochemische Anomalien sind nach wie vor ungelöst.